An Innovation-Driven Company
Our rich pipeline of products, with seven approved NDAs in just seven years, demonstrates our leadership in developing technology-based drugs. Backed by decades of experience, we are able to streamline clinical development time and substantially increase the probability of late-stage product success.
![]() |
TRN-124
Cough & Cold
|
||||||||||||
|
|||||||||||||
![]() |
TRN-110
ADHD in Pediatrics & Adults
|
||||||||||||
|
|||||||||||||
![]() |
TRN-123
Cough & Cold
|
||||||||||||
|
|||||||||||||
![]() |
TRN-112
Cough & Cold
|
||||||||||||
|
|||||||||||||
![]() |
TRN-148
Pediatric CNS
|
||||||||||||
|
|||||||||||||
![]() |
TRN-146
Pediatric CNS
|
||||||||||||
|
|||||||||||||
![]() |
TRN-132
Pain
|
||||||||||||
|
|||||||||||||
![]() |
TRN-133
Urology
|
||||||||||||
|
|||||||||||||
![]() |
TRN-134
Sleep Disorder CNS
|
||||||||||||
|
|||||||||||||
![]() |
TRN-135
Pediatric CNS
|
||||||||||||
|